Active ingredientCenobamateCat. No. P-C113-001CAS 913088-80-9Family · Pharmaceutical analytical standards
Cenobamate
An antiseizure medicine with a carbamate structure and a tetrazole ring, approved in the United States in 2019 and in the European Union in 2021 for focal seizures in adults. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It acts mainly on the 'persistent' current of sodium channels, which fuels neuronal over-excitability, while sparing the 'transient' current needed for normal nerve impulses.
Go to the active ingredient →Active ingredientCenobamateCat. No. P-C113-001CAS 913088-80-9
MetaboliteCenobamate N-GlucuronideCat. No. P-C113-002
Isotopically labelledCenobamate Impurity 1-d4Cat. No. P-C113-003
Isotopically labelledCenobamate-d4Cat. No. P-C113-004
Isotopically labelledrac-Cenobamate-d4Cat. No. P-C113-005
Impurity(S)-CenobamateCat. No. P-C113-006CAS 913088-81-0
ImpurityCenobamate Impurity 1Cat. No. P-C113-007CAS 913088-45-6
ImpurityCenobamate Impurity 2Cat. No. P-C113-008CAS 913089-08-4
ImpurityCenobamate Impurity 3Cat. No. P-C113-009CAS 913089-09-5
ImpurityCenobamate (R)-1-(2,4-dichlorophenyl) ImpurityCat. No. P-C113-010CAS 913088-92-3
ImpurityCenobamate 1-Ethanone ImpurityCat. No. P-C113-011CAS 1259059-68-1
ImpurityCenobamate Impurity 4Cat. No. P-C113-012CAS 1259059-77-2
Impurityrac-CenobamateCat. No. P-C113-013CAS 913087-59-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.